Medirom Healthcare Announces Shareholder Meeting Details

Ticker: MRM · Form: 6-K · Filed: Apr 23, 2025 · CIK: 1819704

Sentiment: neutral

Topics: shareholder-meeting, corporate-governance, filing

TL;DR

Medirom Healthcare is calling its shareholder meeting for FY24, proxy materials are out.

AI Summary

Medirom Healthcare Technologies Inc. announced on April 18, 2025, the convocation of its Ordinary General Meeting of Shareholders for the fiscal year 2024. This filing includes the proxy materials related to this meeting, as required by Japanese Companies Act regulations.

Why It Matters

This filing provides shareholders with essential information and materials needed to participate in the company's annual general meeting, a key governance event.

Risk Assessment

Risk Level: low — The filing is a routine corporate announcement regarding a shareholder meeting and does not contain significant financial or operational news.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to report the convocation of the Ordinary General Meeting of Shareholders of MEDIROM Healthcare Technologies Inc. for the fiscal year 2024 and to provide the accompanying proxy materials.

When was the notice for the shareholder meeting circulated?

The notice and accompanying information were circulated on April 18, 2025.

What regulations govern the circulation of this notice?

The circulation of the notice is in accordance with the rules and regulations of the Japanese Companies Act.

What is the company's principal executive office address?

The company's principal executive offices are located at 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.

Does the company file annual reports under Form 20-F or 40-F?

The company indicates it files annual reports under cover of Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 23, 2025 regarding Medirom Healthcare Technologies Inc. (MRM).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing